The surge in genomics data generation presents both unprecedented opportunities and significant challenges. Conventional analysis methods often struggle to keep pace, leading to Regulatory compliance systems bottlenecks in downstream applications such as disease diagnosis, therapy discovery, and personalized medicine. To address this pressing need,